Skip to main content
← Companies
CLNN

Clene Inc.

Data as of Oct 17, 2026
CLNN
CIK 1822791Pharmaceutical Preparations

Lobbying

$555,000 in reported federal lobbying spend across 17 quarterly filings, most recently Aug 3, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Spend by issue

  • Health Issues$205K9 filings
  • Energy/Nuclear$200K4 filings
  • Medical/Disease Research/Clinical Labs$150K1 filing

Latest filings, Jan 2026 onward

FiledRegistrant and subjectAmount
Aug 3, 2026
LOT SIXTEEN LLC for CLENERA LLC
Energy/Nuclear Federal permitting processes; renewable energy development and advancement
$60,000
Jul 20, 2026
CAPITOL HILL CONSULTING GROUP for CLENE NANOMEDICINE
Health Issues Issues related to accelerated approval.
$0
Jul 17, 2026
LOT SIXTEEN LLC for CLENERA LLC
Energy/Nuclear Federal permitting processes
$60,000
Apr 21, 2026
CAPITOL HILL CONSULTING GROUP for CLENE NANOMEDICINE
Health Issues Issues related to accelerated approval.
$0
Apr 20, 2026
LOT SIXTEEN LLC for CLENERA LLC
Energy/Nuclear Federal permitting processes
$60,000
Jan 20, 2026
CAPITOL HILL CONSULTING GROUP for CLENE NANOMEDICINE
Health Issues Issues related to accelerated approval.
$20,000

Data: FEC (PAC contributions, Schedule A), Quiver Quantitative (congressional holdings, lobbying, contracts), Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Clene Inc. through its SEC registration (CIK 1822791) and tickers CLNN.

As of: lobbying filings through Aug 3, 2026. Snapshot rebuilt Oct 17, 2026.

Holdings values are estimates from disclosed ranges. PAC contributions cover the current and previous election cycle and count only gifts to sitting members' principal campaign committees, so leadership PACs and losing candidates are not included.